| 1/25 | US=86 / Biol/Mol Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. 356 p. (Advances in Experimental Medicina and Biology, 615). ISBN 978-1-4020-6553-8. |
| 2/25 | US=60 / Biol/Mol Karam JA, Hsieh JT. Anti-cancer strategy of transitional cell carcinoma of bladder based on induction of different types of programmed cell deaths. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 25-50. ISBN 978-1-4020-9596-2. APOPTOSE; AUTOFAGIA; CANCER DE BEXIGA; NECROSE; MORTE CELULAR PROGRAMADA; VIAS DE SINALIZACAO |
| 3/25 | US=60 / Biol/Mol Hietanen S. Apoptosis in carcinogenesis and chemotherapy of the uterine cervix. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 51-73. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; PAPILOMAVIRUS HUMANO (HPV) |
| 4/25 | US=60 / Biol/Mol Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA |
| 5/25 | US=60 / Biol/Mol Nicholl MB, Hoon DSB. Apoptosis in cutaneous melanoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 111-25. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; MELANOMA CUTANEO; APAF-1; SURVIVINA; INIBIDORES DE APOPTOSE |
| 6/25 | US=60 / Biol/Mol Li Y, Martin RCG. Apoptosis in carcinogenesis and chemotherapy - esophageal cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 127-56. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; QUIMIOTERAPIA; CANCER DE ESOFAGO; VIAS DE SINALIZACAO; CARCINOMA ESOFAGICO; ADENOCARCINOMA ESOFAGICO |
| 7/25 | US=60 / Biol/Mol Balcer-Kubiczek EK, Garofalo MC. Molecular targets in gastric cancer and apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 157-92. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; ALVOS MOLECULARES; CANCER GASTRICO; REGULADORES DO CANCER; MICRORNA; CELULAS-TRONCO; CANCER GASTRICO. EPIDEMIOLOGIA; CANCER GASTRICO. CLASSIFICACAO PATOLOGICA; CANCER GASTRICO. TRATAMENTO; CANCER GASTRICO. ASPECTOS MOLECULARES; VIAS APOPTOTICAS |
| 8/25 | US=60 / Biol/Mol Yarde DN, Tao J. Apoptosis and the tumor microenvironment in hematologic malignancies. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 193-218. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A DROGA; LEUCEMIA; LINFOMA; MIELOMA MULTIPLO; MICROAMBIENTE DO TUMOR |
| 9/25 | US=60 / Biol/Mol Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE |
| 10/25 | US=60 / Biol/Mol Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA |
| 11/25 | US=60 / Biol/Mol Leung KC, Chen GG. Cyclooxygenase 2 and its metabolites: implications for lung cancer therapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 251-72. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE PULMAO; CICLOOXIGENASE 2; PROSTAGLANDINA; COX-2; QUIMIOTERAPIA |
| 12/25 | US=60 / Biol/Mol Lee MH, Yang H, Zhao R, Yeung SCJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 273-94. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER NASOFARINGEO; REGULADORES DE CRESCIMENTO; CICLO CECLULAR; CARCINOMA NASOFARINGEO; SINALIZACAO DE TRANSDUCAO; REGULADORES DE CRESCIMENTO NEGATIVO; REGULADORES DE CRESCIMENTO POSITIVO |
| 13/25 | US=60 / Biol/Mol Alin N, MacLeod S, Hine RJ, Chowdhury P. Cellular signaling mechanisms in pancreatic apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 295-325. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; MECANISMOS DE SINALIZACAO DE APOPTOSE; FOSFATOS DE INOSITOL; NUTRICAO; CARCINOGENESE PANCREATICA; CANCER DE PANCREAS; BIOMARCADORES; INIBIDORES DE CASPASES; FAMILIA IAP; MECANISMOS ACOPLADOS A PROTEINA- G; POLIFOSFATOS DE INOSITOL; BIOMARCADORES; DIETA; ESTRESSE OXIDATIVO |
| 14/25 | US=60 / Biol/Mol Dinnen RD, Petrylak DP, Fine RL. Strategies to circumvent resistance to apoptosis in prostate cancer cells by targeted necrosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 327-46. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A APOPTOSE; CANCER DE PROSTATA; NECROSE; P53; ESPECIES REATIVAS DE OXIGENIO |
| 15/25 | US=60 / Biol/Mol Liu ZM, Chen GG. Carcinogenesis and therapeutic strategies for thyroid cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 347-74. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; CANCER DA TIREOIDE; TERAPIA ANTI-CANCER; ANGIOGENESE |
| 16/25 | US=85 / Biol/Mol Yosifov DY, Konstatinov SM, Berger MR. Erucylphospho-N,N,N- trimethylpropylammonium shows substantial cytotoxicity in multiple myeloma cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 350-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. MIELOMA MULTIPLO; ERUFOSINE; ALKYLPHOCHOLINES; CITOTOXICIDADE; MORTE CELULAR PROGRAMADA; ATIVACAO DA CASPASE; CLIVAGEM PARP; LIVRE DE CELULAS DO SISTEMA PARA A APOPTOSE |
| 17/25 | US=101 / Câncer Mouro C, Zazzeroni F, Papa S, Bubici C, Franzoso G. The NF-&*1179;B transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-&*1179;B activity. In: Kozlov SV, editor. Inflammation and cancer: methods and protocols. volume 2, molecular analysis and pathways. New York: Humana Press, 2009. p. 169-207. (Methods in Molecular Biology, 512) ISBN 978-1-60327-529-3. CANCER; INFLAMACAO; MORTE CELULAR PROGRAMADA; FATOR NUCLEAR &*1179;B; FATOR DE NECROSE TUMORAL &*945; |
| 18/25 | US=9 / Pediatria Thiele CJ, Khanna C. Biology of childhood cancer. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 86-117. ISBN 978-0-7817-5492-7. ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; BIOLOGIA; FATORES DE CRESCIMENTO; PROTEINAS TIROSINA QUINASES; VIAS DE TRANSDUCAO DE SINAL; FATORES DE CRESCIMENTO EPIDERMICO; FATORES DE CRESCIMENTO FIBROBLASTICOS; RECEPTORES; RECEPTORES DE HORMONIOS NUCLEARES; RETINOIDES; VITAMINA D; CELULAS-TRONCO; CRESCIMENTO CELULAR; PROGRESSAO DO CICLO CELULAR; MORTE CELULAR PROGRAMADA; SENESCENCIA; ANGIOGENESE; METASTASE |
| 19/25 | US=86 / Biol/Mol Bialik S, Kimchi A. Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 177-200. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. AUTOFAGIA; SUPRESSAO DO TUMOR; AUTOFAGICOS; VIAS DE MORTE CELULAR; DESENVOLVIMENTO DE TUMORES; MORTE CELULAR PROGRAMADA; DAPK; BECLIN 1; MTOR |
| 20/25 | US=98 / Biol/Mol Bredesen DE. Toward a mechanistic taxonomy for programmed cell death pathways. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 73-91. ISBN 978-084939192-7. |